Abbott India to co‑launch Extensior with Novo Nordisk India, broadening access to Semaglutide (Ozempic) in India and strengthening its diabetes portfolio with a GLP‑1 therapy.
AI Assistant
Abbott India Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.